About Healius (ASX: HLS)
Healius Limited is an Australian healthcare company focused on the provision of medical laboratory and pathology services across Australia, operating a network of medical laboratories and patient collection centres that serve both clinical and diagnostic needs.
The company delivers its services through a broad portfolio of brands, including Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs. Formerly known as Primary Health Care Limited, the company adopted the Healius name in December 2018. Incorporated in 1994, Healius is headquartered in Sydney, Australia.
MFAM Research
- [BUY] Healius (ASX:HLS) is an Undervalued Healthcare Services Provider in a Growing IndustryOctober 8, 2020Today we’ll look at why we like Healius shares (ASX:HLS) and we’ll give you a rundown of our HLS share price forecast. Healius is a healthcare services provider with three main businesses – pathology, imaging and medical centres. With an aging population and a growing pathology industry, Healius is well-positioned to take advantage of the […]
Latest Announcements
No latest announcements yet.
Financial Summary
Price History
Related Stocks
| Same Industry — Healthcare | Same Sub-Industry — Diagnostics & Research |
|---|---|